References
- Cote C, Hiba B, Hebert LJ, et al. MRI of tibialis anterior skeletal muscle in myotonic dystrophy type 1. Can J Neurol Sci. 2011;38:112–118.
- Park D, Lee SH, Shin JH, et al. Lower limb muscle magnetic resonance imaging in myotonic dystrophy type 1 correlates with the six-minute walk test and CTG repeats. Neuromuscul Disord. 2018;28:29–37.
- Baroni A, Neaga I, Delbosc N, et al. Bioactive aliphatic polycarbonates carrying guanidinium functions: an innovative approach for myotonic dystrophy type 1 therapy. ACS Omega. 2019;4:18126–18135.
- Johnson NE. Myotonic muscular dystrophies. Continuum (Minneap Minn). 2019;25:1682–1695.
- Wenninger S, Montagnese F, Schoser B. Core clinical phenotypes in myotonic dystrophies. Front Neurol. 2018;9:303.
- Meola G, Cardani R. Myotonic dystrophies: an update on clinical aspects, genetic, pathology, and molecular pathomechanisms. Biochim Biophys Acta. 2015;1852:594–606.
- Diaz-Manera J, Fernandez-Torron R, LLauger J, et al. Muscle MRI in patients with dysferlinopathy: pattern recognition and implications for clinical trials. J Neurol Neurosurg Psychiatry. 2018;89:1071–1081.
- Park JS, Park D. Five-year serial follow-up of muscle MRI in adult onset myotonic dystrophy type 1: a case report. Medicine (Baltimore). 2018;97:e9379.
- Regula JU, Jestaedt L, Jende F, et al. Clinical muscle testing compared with whole-body magnetic resonance imaging in facio-scapulo-humeral muscular dystrophy. Clin Neuroradiol. 2016;26:445–455.
- Zhao Y, Liu X, Zhang W, et al. Childhood autoimmune necrotizing myopathy with anti-signal recognition particle antibodies. Muscle Nerve. 2017;56:1181–1187.
- Castillo J, Pumar JM, Rodriguez JR, et al. Magnetic resonance imaging of muscles in myotonic dystrophy. Eur J Radiol. 1993;17:141–144.
- Hamano T, Kawamura Y, Mutoh T, et al. Muscle MRI in myotonic dystrophy type 1 with foot drop. Eur Neurol. 2010;63:144–148.
- Kornblum C, Lutterbey G, Bogdanow M, et al. Distinct neuromuscular phenotypes in myotonic dystrophy types 1 and 2: a whole body highfield MRI study. J Neurol. 2006;253:753–761.
- Peric S, Maksimovic R, Banko B, et al. Magnetic resonance imaging of leg muscles in patients with myotonic dystrophies. J Neurol. 2017;264:1899–1908.
- Mathieu J, Boivin H, Meunier D, et al. Assessment of a disease-specific muscular impairment rating scale in myotonic dystrophy. Neurology. 2001;56:336–340.
- Paoletti M, Pichiecchio A, Cotti Piccinelli S, et al. Advances in quantitative imaging of genetic and acquired myopathies: clinical applications and perspectives. Front Neurol. 2019;10:78.
- Hu Z, Zhu Y, Liu X, et al. FHL1-related clinical, muscle MRI and genetic features in six Chinese patients with reducing body myopathy. J Hum Genet. 2019;64:919–926.
- Li GD, Liang YY, Xu P, et al. Diffusion-tensor imaging of thigh muscles in duchenne muscular dystrophy: correlation of apparent diffusion coefficient and fractional anisotropy values with fatty infiltration. AJR Am J Roentgenol. 2016;206:867–870.
- Xie Z, Xie Z, Yu M, et al. Value of muscle magnetic resonance imaging in the differential diagnosis of muscular dystrophies related to the dystrophin-glycoprotein complex. Orphanet J Rare Dis. 2019;14:250.
- Yu M, Zhu Y, Xie Z, et al. Novel TTN mutations and muscle imaging characteristics in congenital titinopathy. Ann Clin Transl Neurol. 2019;6:1311–1318.
- Zhao J, Wang Z, Hong D, et al. Mutational spectrum and clinical features in 35 unrelated mainland Chinese patients with GNE myopathy. J Neurol Sci. 2015;354:21–26.
- Tasca G, Monforte M, Diaz-Manera J, et al. MRI in sarcoglycanopathies: a large international cohort study. J Neurol Neurosurg Psychiatry. 2018;89:72–77.
- Feng X, Luo S, Li J, et al. Fatty infiltration evaluation and selective pattern characterization of lower limbs in limb-girdle muscular dystrophy type 2A by muscle magnetic resonance imaging. Muscle Nerve. 2018;58:536–541.
- Fatehi F, Salort-Campana E, Le Troter A, et al. Muscle MRI of facioscapulohumeral dystrophy (FSHD): a growing demand and a promising approach. Rev Neurol (Paris). 2016;172:566–571.